Nikolaos Daskalakis

Dr. Nikolaos Daskalakis

Assistant Professor of Psychiatry, Harvard Medical School/ McLean Hospital, MA, USA
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2020 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
MBMichael S. Breen
Michael S. Breen
LBLinda M. Bierer
Linda M. Bierer
Nikolaos DaskalakisNikolaos Daskalakis
Nikolaos Daskalakis
HBHeather N. Bader
Heather N. Bader
IMIouri Makotkine
Iouri Makotkine
RYRachel Yehuda
Rachel Yehuda
This Article was originally published without the correct Supplemental Table file (Table S1 was missing). In total, there are seven Supplemental Tables, and six were in the original submission. Furthermore, Fig. 1 was misplaced in the main text; it was embedded in the manuscript file even before the results section. Both issues have now been fixed in the HTML and PDF versions of this Article.

1 September 2016 in Biological Psychiatry
Verified
Journal Article
Closed access
RYRachel Yehuda
Rachel Yehuda
Nikolaos DaskalakisNikolaos Daskalakis
Nikolaos Daskalakis
LBLinda M. Bierer
Linda M. Bierer
HBHeather N. Bader
Heather N. Bader
TKTorsten Klengel
Torsten Klengel
EBElisabeth B. Binder
Elisabeth B. Binder

8 October 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
CNCaroline Nievergelt
Caroline Nievergelt
AMAdam X. Maihofer
Adam X. Maihofer
TKTorsten Klengel
Torsten Klengel
EAElizabeth G. Atkinson
Elizabeth G. Atkinson
CCChia-Yen Chen
Chia-Yen Chen
KKKarestan C. Koenen
Karestan C. Koenen
The risk of posttraumatic stress disorder (PTSD) following trauma is heritable, but robust common variants have yet to be identified. In a multi-ethnic cohort including over 30,000 PTSD cases and 170,000 controls we conduct a genome-wide association study of PTSD. We demonstrate SNP-based heritability estimates of 5–20%, varying by sex. Three genome-wide significant loci are identified, 2 in European and 1 in African-ancestry analyses. Analyses stratified by sex implicate 3 additional loci in men. Along with other novel genes and non-coding RNAs, a Parkinson’s disease gene involved in dopamine regulation, PARK2, is associated with PTSD. Finally, we demonstrate that polygenic risk for PTSD is significantly predictive of re-experiencing symptoms in the Million Veteran Program dataset, although specific loci did not replicate. These results demonstrate the role of genetic variation in the biology of risk for PTSD and highlight the necessity of conducting sex-stratified analyses and expanding GWAS beyond European ancestry populations.

1 September 2013 in Psychoneuroendocrinology
Verified
Journal Article
Closed access
Nikolaos DaskalakisNikolaos Daskalakis
Nikolaos Daskalakis
RBRosemary C. Bagot
Rosemary C. Bagot
KPKaren J. Parker
Karen J. Parker
CVChristiaan H. Vinkers
Christiaan H. Vinkers
RKRon de Kloet
Ron de Kloet

1 August 2014 in American Journal of Psychiatry
Verified
Journal Article
Closed access
RYRachel Yehuda
Rachel Yehuda
Nikolaos DaskalakisNikolaos Daskalakis
Nikolaos Daskalakis
ALAmy Lehrner
Amy Lehrner
FDFrank Desarnaud
Frank Desarnaud
HBHeather N. Bader
Heather N. Bader
MMMichael J. Meaney
Michael J. Meaney

1 January 2013 in Frontiers in Psychiatry
Verified
Journal Article
Open access
PDF file
RYRachel Yehuda
Rachel Yehuda
Nikolaos DaskalakisNikolaos Daskalakis
Nikolaos Daskalakis
FDFrank Desarnaud
Frank Desarnaud
IMIouri Makotkine
Iouri Makotkine
ALAmy L. Lehrner
Amy L. Lehrner
LBLinda M. Bierer
Linda M. Bierer
Epigenetic alterations offer promise as diagnostic or prognostic markers, but it is not known whether these measures associate with, or predict, clinical state. These questions were addressed in a pilot study with combat veterans with PTSD to determine whether cytosine methylation in promoter regions of the glucocorticoid related NR3C1 and FKBP51 genes would predict or associate with treatment outcome. Veterans with PTSD received prolonged exposure (PE) psychotherapy, yielding responders (n = 8), defined by no longer meeting diagnostic criteria for PTSD, and non-responders (n = 8). Blood samples were obtained at pre-treatment, after 12 weeks of psychotherapy (post-treatment), and after a 3-month follow-up. Methylation was examined in DNA extracted from lymphocytes. Measures reflecting glucocorticoid receptor (GR) activity were also obtained (i.e., plasma and 24 h-urinary cortisol, plasma ACTH, lymphocyte lysozyme IC50-DEX, and plasma neuropeptide-Y). Methylation of the GR gene (NR3C1) exon 1F promoter assessed at pre-treatment predicted treatment outcome, but was not significantly altered in responders or non-responders at post-treatment or follow-up. In contrast, methylation of the FKBP5 gene (FKBP51) exon 1 promoter region did not predict treatment response, but decreased in association with recovery. In a subset, a corresponding group difference in FKBP5 gene expression was observed, with responders showing higher gene expression at post-treatment than non-responders. Endocrine markers were also associated with the epigenetic markers. These preliminary observations require replication and validation. However, the results support research indicating that some glucocorticoid related genes are subject to environmental regulation throughout life. Moreover, psychotherapy constitutes a form of “environmental regulation” that may alter epigenetic state. Finally, the results further suggest that different genes may be associated with prognosis and symptom state, respectively.